Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
The pharmacokinetics of imipenem, a new carbapenem antibiotic, and cilastatin, a metabolic inhibitor, were evaluated in 17 patients with cystic fibrosis. Imipenem and cilastatin were combined in a ratio of 1:1 in the infusion solution, and patients intravenously received 30, 60, or 90 mg of imipenem...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1985
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180100/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.583 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|